scientific committee

 

Philip AshersonProfessor Philip Asherson

Professor of Molecular Psychiatry, Genetic and Developmental Psychiatry Research Centre, King’s College London, UK

Professor Philip Asherson has been a Lead Clinician in the National Adult ADHD Clinic at the Maudsley Hospital, London, UK, since 1998. His research focuses on clinical, quantitative genetic and molecular genetic studies of ADHD in adults and in children, and the clinical assessment and treatment of ADHD in adults. He was a member of the National Institute of Health and Clinical Excellence (NICE) Guideline Development Group for ADHD across the lifespan and is the president of the UK Adult ADHD Network – a national network for the support of clinicians diagnosing and treating ADHD in the UK. Professor Asherson has authored over 270 peer-reviewed articles and book chapters on ADHD and other psychiatric conditions, including two books on ADHD in adults.

Disclosures: Professor Asherson has acted as a consultant for Shire, Lilly, Janssen and Novartis on behalf of King’s College London. On behalf of King’s College London, he has received educational or research grants from Shire, Lilly, Janssen, Vifor Pharma and Qbtech, and presented at educational events organised or sponsored by these companies.

scroll to top

Maite FerrinDr Maite Ferrin

Consultant Psychiatrist, Huntercombe Hospital, Maidenhead, UK
Honorary Research Associate, Department of Child and Adolescent Psychiatry, Institute of Psychiatry London, UK

Dr Maite Ferrin obtained her medical degree at the University of Navarra, Spain, before completing her MSc and PhD research at King’s College London and the University of Granada.

Dr Ferrin has been a full-time Consultant Psychiatrist since 2006, working in Jaen and Navarra, Spain, specialising in child and adolescent psychiatry. She has lead psychoeducation projects for families of ADHD patients in both Spain and London and has sat on the European ADHD Guidelines Group (EAGG, Eunethydis) since 2010. In addition, Dr Ferrin has contributed to the J-Eunethydis organising committee as well as several Spanish groups working to improve ADHD treatment (GEITADH, GEIDA). Dr Ferrin is also active in ADHD research, with a number of peer-reviewed publications to her name. She is a peer reviewer for several international child and adolescent psychiatry journals and Deputy Editor of the IACAPAP (International Association for Child and Adolescent Psychiatry and Allied Professions) bulletin.

Disclosures: Dr Ferrin has received economic support from the Instituto de Salud Carlos III (ETS 07/90902, BAE 09/90088), Consejeria de Salud Junta de Andalucıa (EF-0029) Fundacion Alicia Koplowitz and Gobierno de Navarra (Beca Ayanz). She declares no other conflict of interest.

scroll to top

Photo - Margaret WeissProfessor Margaret Weiss

Head at Weiss Clinic for ADHD Care West Vancouver, British Columbia, Canada
Clinical Professor in Psychiatry, University of British Columbia

Professor Margaret Weiss obtained her PhD in the History of Medicine at Harvard University and then trained in medicine and psychiatry at McGill University. She was the Director of the Provincial ADHD Program at British Columbia Children’s Hospital for 15 years.

Professor Weiss is a Clinician and Researcher, specialising in ADHD throughout the life cycle. She also helped launch, and participated in writing, the Canadian guidelines for ADHD for the last four editions. Professor Weiss wrote the first major textbook on adult ADHD, has authored chapters on ADHD in several psychiatric textbooks, has over one hundred publications to her name and is an Editor of multiple journals; however, Professor Weiss is best known for her research on the effect of melatonin on insomnia in ADHD and the creation of the Weiss Functional Impairment Rating Scale, which is now approved by the FDA and officially translated into 13 languages.

Professor Weiss is a world-renowned speaker who has worked and taught throughout Canada, China, Denmark, France, Germany, Holland, Korea, Mexico, Norway, Spain, Sweden, Switzerland, Turkey, the UK and the USA.

Disclosures: Prof Weiss has acted as speaker for Purdue Pharma, Janssen, Eli Lilly and Shire and has also received research grants, consultant fees and honoraria from these companies.

scroll to top

mats-johnsonDr Mats Johnson

Chief Physician, Child Neuropsychiatry Unit, Queen Silvia’s Hospital for Children, Gothenburg, Sweden
Researcher, Gillberg Neuropsychiatry Centre, Sahlgrenska Academy, University of Gothenburg

Dr Mats Johnson is a Chief Physician, overseeing the assessment and treatment of neuropsychiatric disorders in children and adolescents at Queen Silvia’s Hospital, Gothenburg, Sweden. In his capacity as a researcher, Dr Johnson is based at the Gillberg Child Neuropsychiatry Centre, University of Gothenburg, and his research focuses on interventions for ADHD, oppositional defiant disorder, neurodevelopmental disorders, challenging behaviours, and conduct disorder in children and adolescents. He has a number of peer-reviewed articles to his credit and has recently been awarded his PhD.

Disclosures: Dr Johnson has received research support from Equazen/Vifor Pharma, Shire, The Wilhelm and Martina Lundgrens Foundation and the Swedish MRC. Funders have had no involvement in study design, data collection or analysis, manuscript preparation or publication decisions. He has received honoraria as a speaker and advisory board member from Lilly, Janssen, Novartis, Shire and Vifor Pharma.

scroll to top

Dr Iris Manor

Head of the ADHD Unit, Geha Mental Health Center, Petach-Tiqva, Israel
Senior Lecturer of Psychiatry, Scskler School of Medicine, Tel Aviv University, Israel

Dr Iris Manor is a Board Member in the European Network of Adult ADHD (ENAA), as well as the American Professional Society of ADHD and Related Disorders (APSARD). She is also a Board Member and Secretary of the ADHD section of the World Psychiatric Association (WPA) and has herself organised several ADHD meetings and symposia. Dr Manor was Chair of the Scientific Committee of the 2013 ADHD Worldwide conference in Israel and is Head of the medical branch of the non-profitable Israeli organisation Kavim U’Machshavot, which is dedicated to ADHD in the community.

Dr Manor is the author of one book, several book chapters and around 70 peer-reviewed articles, most of them on ADHD.

Disclosures: Dr Manor has been a consultant to or has received honoraria or grants from Janssen Cilag, Novartis Israel, Teva Israel, Madisson Israel, Enzymotec Ltd and Alcobra Ltd.

scroll to top

prof_ramos_106x106Professor Josep Antoni Ramos-Quiroga

Professor of Psychiatry at the Universitat Autònoma de Barcelona
Coordinator of the ADHD program at the Hospital Universitari Vall d’Hebron

Professor Josep Antoni Ramos-Quiroga is a Professor of Psychiatry at the Universitat Autònoma de Barcelona, Spain, and Coordinator of the ADHD program in the Department of Psychiatry at the Hospital Universitari Vall d’Hebron in Barcelona. He is Chair of the ‘Neurodevelopmental Disorders Across the Lifespan’ section of the European Psychiatric Association.

Professor Ramos-Quiroga’s research focuses on ADHD in adolescents and adults, including clinical trials, drug trials, neuroimaging studies and genetics. He is a member of the European Network Adult ADHD, the International Multicentre persistent ADHD CollaboraTion (IMpACT), and the International Collaboration on ADHD and Substance Abuse (ICASA).

Professor Ramos-Quiroga is the author of more than 100 international publications and five books, and has spoken and presented at national and international conferences on ADHD. He has participated in several groups of government experts on ADHD. He organises the theoretical and practical courses of ‘ADHD across the lifespan’ at the Hospital Universitari Vall d’Hebron (15th edition).

Disclosures: Professor Ramos-Quiroga has received educational or research grants from Shire and has acted as speaker for both Shire and Lilly. He has also received honoraria or consultation fees from these companies.

scroll to top

Registration and login

To register for access to the Continuum eLearning series, please click here. Please note: the Continuum eLearning series is only available to healthcare professionals.

If you have already registered, to login, please click here.